Literature Search

Shalaby(A),Hany(H),Ramez(AM),Metwally(IH),El… Clin Transl Oncol 2026-09-00

...MSH2, MSH6, PMS2), along with CDX2 and SATB2, in relation to clinicopathologic characteristics and the survival outcome....

Lowry(C),Laurent(C),Bindra(AK),Powell(CB),Ga… Hered Cancer Clin Pract 2026-03-19

...MSH2/EPCAM, MSH6 or PMS2 tested between 01/01/2015 and 12/31/2018. Clinical and demographic characteristics were abstrac...

Trinh(HD),Pham(QT),Phong(NH),Huong Ly(TT),Ho… Cancer Manag Res None

...MSH2, and MSH6), and PCR assay. Clinicopathological characteristics were collected and compared between dMMR tumors and ...

Hashimoto(H),Koda(H),Nakajima(K),Mizukami(T)… Pathol Int 2026-03-00

...MSH2 and MSH6 expression, indicating mismatch repair deficiency (dMMR), and molecular analysis confirmed microsatellite ...

Mo(H),Zhang(W),Wei(J),Chen(J),He(J),Zeng(X),… BMC Cancer 2026-03-24

...MSH2, with MSH6 being the most frequent. Patients harboring MSH6 pathogenic mutations had a significantly older average ...

Amir-Kabirian(B),AlRubaye(R),Cadle(B),Mais(D… JCEM Case Rep 2026-04-00

...MSH2) splice-site mutation, indicating microsatellite instability. The patient started pembrolizumab immunotherapy, resu...

Travlos(P),Pergaris(A),Lazaris(AC),Thymara(E… Per Med 2026-02-00

...MSH2, MSH6, PMS2) via IHC and five mononucleotide markers (BAT25, BAT26, NR21, NR24, NR27) via PCR. Discordant cases (pM...

Sohrabi(M),Valizadeh(A),Molavand(M),Yousefi(… Drug Res (Stuttg) 2026-03-17

...MSH2, MSH6, and PARP1, was evaluated by quantitative real-time polymerase chain reaction and western blot. Also, the act...

Le(BV),Vekariya(U),Toma(MM),Nieborowska-Skor… Cell Rep Med 2026-03-17

...MSH2/MSH3 repressive complex to DSBs is diminished in DNMT3Amut leukemia cells, which facilitates association of Polθ wi...

Ghaderi(H),Mohammadi(Y),Ahmadvand(S),Safaei(… Int Arch Otorhinolaryngol 2026-01-00

...MSH2, MSH6, and PMS2 of the MMR proteins family and CD45RO were evaluated using immunohistochemistry (IHC). Hematoxylin ...